// App-Quantinova.ai

1279 : Longitudinal Study on Determinants of Health-Related Quality of Life in Patients with Myelodysplastic Syndromes

Researchers

Presenter

  • Igor Stojkov

Principal Investigators

  • Ursula Rochau

  • Marjan Arvandi

  • Karin A Koinig

  • Michael Schomaker

  • Pierre Fenaux

  • David Bowen

  • Argiris Symeonidis

  • Moshe Mittelman

  • Jaroslav Cermak

  • Guillermo F Sanz

  • Eva Hellstrom Lindberg

  • Luca Malcovati

  • Saskia Langemeijer

  • Ulrich Germing

  • Mette Skov Holm

  • Krzysztof Madry

  • Agnes Guerci Bresler

  • Dominic J. Culligan

  • Ioannis Kotsianidis

  • Laurence Sanhes

  • Juliet Mills

  • Sibylle Puntscher

  • Daniela Schmid

  • Corine Van Marrewijk

  • Alexandra Smith

  • Theo de Witte

  • Uwe Siebert

  • Reinhard Stauder

Medical Centers

  • Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology,Hall in Tirol,Austria

  • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University (IMU), Innsbruck, Innsbruck, Austria

  • Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7,Paris,France

  • St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom

  • Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece

  • Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty,Tel Aviv University,Tel Aviv,Israel

  • Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Hematology, Hospital Universitario La Fe, Valencia, Spain

  • Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden

  • Department of Hematology Oncology,Fondazione IRCCS Policlinico San Matteo,University of Pavia,Pavia,Italia

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Hematology, Oncology and Clinical Immunology, Universitaetsklinikum Duesseldorf, Duesseldorf, Germany,

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Department of Haematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

  • Service dHematologie Clinique, Centre Hospitalier Universitaire dAngers, Angers, France

  • Dept of Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  • Department of Hematology, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece

  • Haematology Department of Perpignan, Saint Jean Hospital, Perpignan, France

  • Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom

  • Division for Quantitative Methods in Public Health and Health Services Research, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall In Tirol, Austria

  • Epidemiology and Cancer Statistics Group, Department of Health Sciences,University of York,York,United Kingdom

  • Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, Netherlands

  • UMIT, Dept. of Public Health, Health Services Research & HTA / Harvard Univ., Dept. Health Policy & Management, Institute for Technology Assessment, Hall i. T. (Austria) /, Boston, MA

Locations

  • Austria

  • France

  • United Kingdom

  • Greece

  • Israel

  • Czech Republic

  • Spain

  • Sweden

  • Italy

  • Netherlands

  • Germany

  • Denmark

  • Poland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myelodysplastic Syndrome

  • Depression

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A